Project Grant K99DE032311
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded $426,250 to the University of Kansas Medical Center Research Institute, Inc. on August 14, 2025, under the Oral Diseases and Disorders Research program (CFDA 93.121) to support basic research on pathogenic mechanisms in Streptococcus sanguinis. The two-year project, concluding August 13, 2027, will characterize two endopeptidases (SEPM homologs) encoded by this oral bacterium that can...
- This $515,926 Project Grant awarded by the National Science Foundation (NSF) Engineering program (CFDA 47.041) will fund research to develop an in vitro gingival (gum) tissue system to study the role of microbial communities on oral health and disease. The 5-year project, beginning June 1, 2024, will be conducted by the University of Massachusetts Lowell's Office of Research Administration-Lowell. The key objectives are: (1) developing and validating a microphysiological system to study oral...
- This federal Project Grant award in the amount of $469,830.00 was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The grant aims to identify oral bacterial species with anti-cancer properties and evaluate their potential for preventing or treating oral squamous cell carcinoma (OSCC). Specifically, the study will assess the effects of Streptococcus mitis and Haemophilus parainfluenzae on OSCC...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded $540,629 to the University of Massachusetts Lowell on August 15, 2025, under the Oral Diseases and Disorders Research program (CFDA 93.121) to support research investigating human oral host-pathogen interactions and dysbiosis modulation. The project, scheduled for completion by August 14, 2027, focuses on developing and validating an immunocompetent three-dimensional (3D) in vitro model...
- Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR), under its Oral Diseases and Disorders Research program (CFDA 93.121), awarded the University of Florida Division of Sponsored Research a Project Grant of $952,825 beginning August 1, 2025 and concluding April 30, 2030. The funded research investigates the molecular mechanisms sustaining Kaposi's Sarcoma-Associated Herpesvirus (KSHV) infection in oral epithelial cells, with particular focus on how oral...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $649,046 Project Grant to the Regents of the University of Minnesota, effective June 1, 2026 through February 28, 2031, under the Oral Diseases and Disorders Research program (CFDA 93.121). The research project investigates the molecular mechanisms by which Streptococcus gordonii, a pioneer colonizer bacterium, shapes early dental plaque biofilm community development through transcriptional...
- Summary Case Western Reserve University received a $340,149 Project Grant from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) awarded February 4, 2026, with completion targeted for February 3, 2028. The award funds development of an Atlas of Bacterial Physiology in the Human Oral Cavity, which will characterize gene expression patterns of key oral pathogens, pathobionts, and commensal bacteria across...
- Federal Project Grant Award Summary Baylor College of Medicine received a $453,797 Project Grant from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), awarded June 5, 2026, with completion scheduled for June 4, 2028. The award supports research into the structures and functions of natural products in periodontal disease, specifically investigating a novel biosynthetic gene cluster (BGC) identified in clinical...
- This $431,750 federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) supports research to decipher the mechanisms by which two proteins, AAFLP-1 and AADCUB, regulate the production of exopolysaccharide (PNAG) in the oral bacterium Aggregatibacter actinomycetemcomitans. The research aims to investigate how these two proteins, which are unique to A. actinomycetemcomitans, independently...
- Federal Project Grant Award Summary Oregon Health & Science University (OHSU) received a $524,669 Project Grant from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), effective June 1, 2026 through February 28, 2031. The research project, titled "Exploring Streptococcus Sanguinis Extracellular Vesicles as Regulators of Gingival Homeostasis and Periodontal Defense," investigates how...
DETERMINING THE MECHANISM AND IMPACT OF STREPTOCOCCAL RAS-RIPPS ON THE HUMAN ORAL MICROBIOME - PROJECT SUMMARY THE HUMAN ORAL MICROBIOME IS HOME TO A UNIQUE GROUP OF BACTERIA WITH THE ABILITY TO AFFECT THE OVERALL HEALTH OF THE HUMAN HOST: STREPTOCOCCI SPP. THIS GROUP IS INVOLVED IN A WIDE RANGE OF DISEASES, FROM DENTAL CARIES TO INFECTIVE ENDOCARDITIS. THEY INCLUDE IMPORTANT ORAL PATHOGENS SUCH AS THE CARIOGENIC STREPTOCOCCUS MUTANS AND COMMENSAL ORGANISMS SUCH AS STREPTOCOCCUS MITIS. THESE IMPORTANT ORAL MEMBERS PRODUCE A LARGE ARRAY OF RADICAL-S-ADENOSYLMETHIONINE RIBOSOMALLY SYNTHESIZED AND POST-TRANSLATIONALLY MODIFIED PEPTIDES (RAS-RIPPS). THE NEWLY IDENTIFIED COMPOUNDS INCLUDE A WEALTH OF CHEMICAL STRUCTURES AND HAVE BEEN FOUND TO INHIBIT THE GROWTH OF OTHER ORAL STREPTOCOCCI, AS WELL AS MODULATE THE BEHAVIOR OF PRODUCER ORGANISMS THEMSELVES. THE INITIAL GOAL OF THIS PROPOSAL IS TO ELUCIDATE THE MECHANISM OF ACTION OF THE RAS-RIPP TRYGLYSIN FROM S. MUTANS, AND TO EXAMINE ITS IMPACT ON THE FUNCTIONAL ORAL MICROBIOME. UPON DEFINING TRYGLYSIN'S MECHANISM OF ACTION ON ORAL STREPTOCOCCI AND THE ORAL MICROBIOME, THIS STUDY WILL BE EXPANDED TO EXAMINE THE BIOLOGICAL SIGNIFICANCE OF OTHER RAS-RIPPS PRODUCED BY STREPTOCOCCI: STREPTOSACTIN, SUISACTIN, ROTAPEPTIDES, AND NXXC FAMILY PEPTIDES. WHILE THE CHEMICAL STRUCTURE AND SYNTHESIS OF THESE PEPTIDES HAS BEEN DEFINED, THE BIOLOGICAL SIGNIFICANCE OF THESE IDENTIFIED RAS-RIPPS IS UNEXPLORED. GIVEN THE IMPORTANT STATUS OF STREPTOCOCCI SPP. TO THE HEALTH OF THE HUMAN ORAL MICROBIOTA, THIS REPRESENTS A MAJOR GAP IN KNOWLEDGE ABOUT A CLASS OF PEPTIDES WITH HUGE POTENTIAL IMPACTS ON OVERALL ORAL HEALTH. THIS PROPOSAL AIMS TO CREATE A RESEARCH PLATFORM FOR STUDYING RAS-RIPPS FROM ORAL STREPTOCOCCI, DEFINING THEIR FUNCTION, AND EXAMINING SHIFTS IN THE FUNCTIONAL ORAL MICROBIOME IN RESPONSE TO THEIR PRODUCTION. EXECUTING THIS RESEARCH PROGRAM AT THE UNIVERSITY OF ILLINOIS AT CHICAGO (UIC) WILL ALLOW FOR THE ESTABLISHMENT OF THE CANDIDATE AS AN INDEPENDENT RESEARCHER AND PROVIDE AVENUES FOR THE ACHIEVEMENT OF THE CANDIDATE'S CAREER GOALS: ESTABLISHING A PRODUCTIVE AND FIRST-RATE RESEARCH LABORATORY AND SECURING A TENURED FACULTY POSITION AT A MAJOR RESEARCH INSTITUTION.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 8/21/25 | ||
| Not listed | $0 | 7/9/25 | ||
| Not listed | $0 | 7/9/25 | ||
| Not listed | $111.7k | 7/21/23 |